The Deceptive Nature Of Pharmaceutical Colonialism

  1. Pharmaceutical colonialism is particularly insidious because it lacks all visible characteristics of brutal colonialism. To the contrary, pharmaceutical colonialism is being deceptively presented to millions of people in Africa and the developing world under the veil of “charity for people in need” and disguised as “help for people suffering from diseases.”
  2. Pharmaceutical colonialism is hard to recognize because it is deceptively camouflaged. As opposed to the openly brutal appearance of the colonialism of past centuries, today’s pharmaceutical colonialism comes in disguise and has – largely unrecognized by the people – infiltrated government bodies, corporate structures and civil society in many countries.
  3. However, as perfectly disguised as these interests of pharmaceutical colonialism may be operating within any society, they can be recognized by their common denominator: they all seek to cement and expand the monopoly of the investment business with patented pharmaceutical drugs on global health.
  4. Pharmaceutical colonialism seeks to expand its global rule just like the colonialism of previous centuries. In countries where the pharmaceutical investment interests do not directly control the government they will not rest until they have reached this goal by political, economic, and other means. Towards this end the stakeholders of pharmaceutical interests are being placed in all strategic sectors of society, including politics, media, pharmaceutically-oriented medicine and civil organisations.

Civil Society As A Strategic Target Of Pharmaceutical Colonialism

  1. The stakeholders of pharmaceutical colonialism are masters of “deception and confusion”, a tool they strategically use to “divide and conquer”. In order to cement its control within a society it passes all boundaries of social class, religion and colour. The strategic instruments used to cement this control are the shares of drug companies.
  2. While in the developing world, only a minority of people have the financial resources to buy stock of pharmaceutical companies, the stakeholders of pharmaceutical colonialism are strategically lobbying the investments of “institutional investors” such as the pension funds of trade unions and similar financial resources from civil society organisations.
  3. Largely unbeknown to the members of these civil organizations, their leaders are thereby strategically co-opted to become servants of pharmaceutical colonialism and instruments of cementing its continuous reign. Most significantly, millions of poor members of mass organisations, like trade unions, are thereby unwillingly forced to finance the continuation of pharmaceutical colonialism with their own money. Thus, millions of people belonging to such an organization are harmed twice: they are robbed of their own money that is being used to finance the “business with disease” of pharmaceutical colonialism that feeds of their own bodies, as well as diseases spread among their families and communities.
  4. In a similar way, the stakeholders of pharmaceutical colonialism are strategically infiltrating other sectors of civil society, including churches. In this case, the influence is being bought by “donations” from churches and charitable organizations – mostly located within the leading pharmaceutical export nations.
  5. Unbeknown to millions of believers in developing countries, these charitable organizations abroad are frequently set up or financed by the pharmaceutical industry and some of their leaders – including some church leaders abroad – have close relations to these interests. By means of these “donations,” frequently allocated to finance the purchase of drugs by churches and communities in the developing world, pharmaceutical colonialism even abuses religious organizations. This is a particularly malicious instrument, because it violates the beliefs and sincerity of millions of church members.